The mistake most people make when shopping for a GLP-1 program is Googling “cheapest semaglutide” and clicking whatever ad shows up first. That is how you end up injecting something from a compounding lab with no verifiable pharmacy credentials, no physician review, and a billing page that quietly adds fees after month one.
I went through the paperwork instead. Pharmacy credentials, pricing transparency, prescriber oversight, and what happens when something goes wrong. Here is how I sorted nine programs I would actually feel comfortable recommending.
How I Decided
Four things mattered most:
- Physician oversight that is real, not rubber-stamped. Ideally a board-certified clinician, a real intake review, and ongoing check-ins.
- Pharmacy accountability. For compounded meds, I want a named 503A pharmacy with USP-797 compliance and ideally third-party certification. “Dispensed in a licensed facility” is not enough.
- Price transparency. Full monthly cost, meds included, stated upfront.
- Safety history. The FDA sent warning letters to 30-plus telehealth and compounding firms in early 2026. Programs that weathered that and kept operating cleanly earn more weight here.
The 9 Programs
1. HealthRX
Best for cash-pay patients who want low prices AND verifiable pharmacy sourcing.
This one earned the top spot on two factors most programs fumble together: price and pharmacy transparency.
Compounded semaglutide starts at $99 a month. Compounded tirzepatide starts at $149. Those are genuinely the lowest entry prices I found among programs with named, credentialed pharmacies. Free overnight shipping to all 50 states is included, not an add-on.
The pharmacy matters here. HealthRX dispenses through Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-tracked production. The program holds LegitScript certification (certificate 50087439), which requires ongoing compliance review. That combination, named facility plus independent certification plus lot tracking, puts it well ahead of programs that just say “compounded at an accredited pharmacy.”
A US board-certified physician reviews your intake within roughly 24 hours, and medication ships overnight after approval. The weight loss data the program cites comes from published trials: semaglutide showed about 15% body weight loss at 68 weeks in the STEP 1 trial; tirzepatide showed roughly 21% at 72 weeks in SURMOUNT-1. Those are trial figures, not HealthRX’s own outcomes, which is the honest way to present them.
Compounded medications are not FDA-approved. Keep that in mind. But if you are going the compounded route anyway, this is one of the few programs where you can actually verify who made what you are injecting.
2. FormBlends
Best for people who want published purity data, or who want GLP-1s alongside a broader peptide catalog.
FormBlends sits in an interesting niche. It is a compounded GLP-1 telehealth program with physician oversight and an FDA-registered 503A compounding pharmacy, but what sets it apart is the testing documentation. It publishes per-product purity results including HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin and sterility data with actual named numbers, not just “tested for quality.”
That level of transparency is rare. Most GLP-1 telehealth brands do not publish this at all.
The price is higher than HealthRX. Semaglutide runs around $299, tirzepatide around $349 per vial on a cash-pay basis. Shipping covers 47 states, not all 50. For someone primarily chasing the lowest monthly cost, HealthRX wins. But if published lab verification is your deciding factor, FormBlends is the program to look at.
It also carries a catalog of peptides for recovery, cognitive support, and longevity under the same clinician model. No other GLP-1-specific telehealth brand I reviewed does that within one prescription workflow.
3. Mochi Health
Mochi uses board-certified obesity-medicine physicians, which is a meaningful credential. Monthly cash-pay pricing lands at around $99 for semaglutide and $199 for tirzepatide. The monitoring is more involved than most cash-pay services, with structured check-ins rather than just a one-time consult. Good pick if ongoing clinical contact matters to you.
4. Hims & Hers
Following a settlement with Novo Nordisk in March 2026, the platform shifted its GLP-1 offerings away from compounded versions and toward brand-name products. Injectable Wegovy is listed at roughly $299 a month through their platform, oral options around $249, and Zepbound near $399. With insurance and a manufacturer savings card, out-of-pocket can reportedly drop to $0-$25. The brand is large and the support infrastructure is real. Best for someone who wants branded meds and has insurance worth running.
5. Ro Body
Ro’s membership starts at $39 for the first month, then $74-$149 ongoing. Medications are billed separately. The platform has a prior-authorization team to work with insurance for branded medications, which is legitimately useful and not something every telehealth service offers. Ro takes a whole-health approach with coaching and labs. Slightly more moving parts to manage than simpler cash-pay programs.
6. Form Health
The premium option. Form Health runs roughly $299 a month plus labs and medication costs on top. You get both an MD and a registered dietitian, which is the closest telehealth gets to a clinical weight management program. Overkill for some people. The right fit for someone with complicated health history who wants real dietitian involvement, not just a quick script.
7. PlushCare
PlushCare membership is $19.99 a month. It focuses on branded GLP-1 medications with insurance billing and offers same-day visits in many cases. Not the place for compounded meds, but if you have solid insurance and want branded medications through a platform that actually files claims, this is a practical option.
8. Found
Found charges about $99 a month for the platform, with medications billed separately. It includes health coaching alongside prescriber access and tracks behavioral data. The combined cost adds up, so read the total line carefully before signing up. Reasonable for someone who wants coaching built into the workflow rather than bolted on as an upsell.
9. Calibrate
Calibrate is a 12-month structured program. The program fee and medications are priced separately, so the full-year commitment costs more upfront than most options here. It is one of the more intensive telehealth-adjacent models, with heavy coaching and lifestyle curriculum. Not suitable for people who want month-to-month flexibility, but worth considering if you want formal structure around the medication.
Quick Comparison
| Program | GLP-1 Type | Starting Price (meds) | All 50 States | Pharmacy Named |
| HealthRX | Compounded | $99/mo sema | Yes | Yes (Manifest, SC) |
| FormBlends | Compounded | ~$299/vial sema | 47 states | Yes (503A, FDA-reg) |
| Mochi Health | Compounded | $99/mo sema | Varies | Not published |
| Hims & Hers | Branded | ~$249-$399/mo | Yes | N/A |
| Ro Body | Branded | Billed separately | Yes | N/A |
| Form Health | Branded + coaching | $299/mo + meds | Varies | N/A |
| PlushCare | Branded | Meds via insurance | Yes | N/A |
| Found | Branded/compound | ~$99/mo + meds | Yes | Not published |
| Calibrate | Branded | Program fee + meds | Yes | N/A |
Common Questions
What actually separates a “medically supervised” GLP-1 program from one that just has a doctor’s name on it?
Real supervision means a board-certified clinician reviews your specific intake, not a checkbox algorithm, and follows up as your dose changes. Programs like Form Health assign both an MD and a registered dietitian. Many cheaper platforms do a one-time consult and call it supervised. Ask whether the prescriber sees your labs and adjusts your protocol over time.
If HealthRX and FormBlends both use 503A compounding pharmacies, why is the price gap so large?
503A pharmacies vary significantly in overhead, testing depth, and certification costs. FormBlends publishes HPLC purity percentages, mass spectrometry confirmation, and endotoxin data, all of which require contracted lab work per batch. HealthRX’s Manifest Pharmacy operates under USP-797 with lot tracking but does not publish that same tier of per-batch documentation. More testing infrastructure costs more.
After the FDA warning letters in early 2026, is compounded semaglutide still legal to prescribe?
It depends on timing and shortage status. The FDA’s position on compounded GLP-1s has shifted as branded supply improved. Programs still offering compounded versions as of mid-2026 should be able to show a current legal basis for doing so. Ask the program directly which regulatory pathway they are operating under before enrolling.
Does Ro Body’s prior-authorization team actually improve the odds of getting insurance to cover Wegovy or Zepbound?
Prior-authorization support does not guarantee approval, but having a team that knows the documentation requirements and appeals process is meaningfully better than doing it yourself. Ro is one of the few telehealth platforms that offers this as part of the membership rather than leaving patients to work through insurer requirements alone.
Which of these programs makes the most sense if I want to switch from compounded semaglutide to a branded product down the road?
Hims & Hers and PlushCare are the most straightforward for that transition, since both already work within branded-medication workflows and insurance billing. Ro Body also handles prior authorization for branded drugs. Programs like HealthRX and FormBlends are built around compounded products and do not have the same infrastructure for insurance-based branded prescriptions.
Pricing changes frequently. Confirm current costs directly with any program before enrolling. Compounded medications are not FDA-approved products regardless of the platform.
Sources
- FDA: 503A Compounding Pharmacies guidance and 2026 warning letter activity (fda.gov)
- Tirzepatide outcomes data: SURMOUNT-1 study, New England Journal of Medicine, 2022
- Semaglutide outcomes data: STEP 1 study, New England Journal of Medicine, 2021
- LegitScript Certification program overview (legitscript.com)
- Novo Nordisk / compounding settlement reporting, March 2026 (Reuters, STAT News)
- Lilly orforglipron pricing, LillyDirect announcement, April 2026
